Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease

Internal Medicine Journal

Volumn 38, Issue 3, 2008, Pages 183-189

  Senturk, O ^a   Kocaman, O ^a   Hulagu, S ^a   Sahin, T ^a   Aygun, C ^a   Konduk, T ^a   Celebi, A ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Cardiovascular complication; Endothelial dependent dilatation; Endothelial independent dilatation; Non alcoholic fatty liver disease

Indexed keywords

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; GASTROENTEROLOGY; HOSPITAL ADMISSION; HUMAN; INTRAVASCULAR ULTRASOUND; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ADULT; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; TURKEY; VASCULAR DISEASES;

EID: 39449113333     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01481.x     Document Type: Article

References (38)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003 289 : 76 9.
2. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 2004 5 : 27 42.
3. Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Liver Int 2006 26 : 566 71.
4. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002 105 : 576 82.
5. Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS et al. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol 2004 24 : 739 43.
6. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004 110 : 1245 50.
7. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 2005 42 : 928 40.
8. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005 41 : 1074 84.
9. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003 34 : 1 10.
10. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999 31 : 51 60.
11. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989 79 : 93 100.
12. Yang Z, Ming X-F. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006 4 : 53 65.
13. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004 109 : 2518 23.
14. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992 340 : 1111 15.
15. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995 74 : 247 53.
16. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002 39 : 257 65.
17. Dijkhorst-Oei LT, Stroes ES, Koomans HA, Rabelink TJ. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol 1999 33 : 420 24.
18. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999 94 : 2467 74.
19. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 97.
20. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002 123 : 1705 25.
21. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 21 : 1011 53.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 19.
23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000 85 : 2402 10.
24. Yngve F-Y, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001 21 : 17 26.
25. Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998 11 : 560 65.
26. Fonseca VA. Risk factors for coronary heart disease in diabetes. Ann Intern Med 2000 133 : 154 6.
27. Day CP, James OFW. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998 114 : 842 5.
28. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002 45 : 623 34.
29. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 1996 98 : 894 8.
30. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003 285 : E123 9.
31. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005 42 : 473 80.
32. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 2006 14 : 2127 31.
33. Sarkar K, Sinha AK, Mehta JL. The role of statins in endothelial dysfunction in hypertension. Curr Opin Cardiol 2006 21 : 316 21.
34. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998 29 : 495 501.
35. Aygun C, Senturk O, Hulagu S, Uraz S, Celebi A, Konduk T et al. Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2006 18 : 175 80.
36. Federico A, Trappoliere M, Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Dig Liver Dis 2006 38 : 789 801.
37. Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. Nonalcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis 2004 36 : 165 73.
38. Fonseca V, Desouza C, Asnani S, Jialal I. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev 2004 25 : 153 75.